etoposide and concanavalin a
etoposide has been researched along with concanavalin a in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Duguet, M; Jaxel, C; Mirambeau, G; Panijel, J; Portemer, C; Taudou, G | 1 |
Eibl, MM; Kaider, A; Krainer, M; Kratzik, C; Wilfing, A; Wiltschke, C; Wolf, HM; Zielinski, CC | 1 |
Osann, KE; Slater, LM; Stupecky, M; Sweet, P | 1 |
Kenna, T; Mattarollo, SR; Nicol, AJ; Nieda, M | 1 |
Demirbilek, M; Demirbilek, ME; Denkbaş, EB; Erdal, E; Kavaz, D; Saglam, N; Sam, M | 1 |
Other Studies
5 other study(ies) available for etoposide and concanavalin a
Article | Year |
---|---|
Topoisomerase inhibitors induce irreversible fragmentation of replicated DNA in concanavalin A stimulated splenocytes.
Topics: Animals; Camptothecin; Concanavalin A; DNA; DNA Replication; DNA Topoisomerases, Type II; Etoposide; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred C57BL; Novobiocin; Phenylmethylsulfonyl Fluoride; Spleen; Sulfones; Topoisomerase II Inhibitors | 1988 |
Transient increase in mitogen-induced lymphoproliferative responses in patients with testicular cancer after BEP chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Concanavalin A; Etoposide; Germinoma; Humans; Immunity, Cellular; Lectins; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Receptors, Interleukin-2; Testicular Neoplasms | 2000 |
Enhancement of leukemia rejection by mice successfully treated for L1210 leukemia due to low dose compared to high dose VP-16.
Topics: Animals; Antineoplastic Agents, Phytogenic; Concanavalin A; Cyclosporine; Cyclosporins; Drug Screening Assays, Antitumor; Etoposide; Graft Rejection; Immunosuppressive Agents; Leukemia L1210; Lymphocyte Activation; Mice; Mice, Inbred DBA; Neoplasm Transplantation; Phytohemagglutinins | 2002 |
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Cell Line, Tumor; Cisplatin; Colorectal Neoplasms; Concanavalin A; Cytotoxicity, Immunologic; Diphosphonates; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Genes, T-Cell Receptor delta; Genes, T-Cell Receptor gamma; Humans; Imidazoles; Interferon-gamma; Lovastatin; Lung Neoplasms; Male; Membrane Glycoproteins; Neoplasms; Perforin; Pore Forming Cytotoxic Proteins; Prostatic Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Urinary Bladder Neoplasms; Vincristine; Zoledronic Acid | 2007 |
Preparation and characterization of magnetically responsive bacterial polyester based nanospheres for cancer therapy.
Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Concanavalin A; Cupriavidus necator; Etoposide; HeLa Cells; Humans; Magnetite Nanoparticles; Materials Testing; Nanocapsules; Nanospheres; Polyhydroxyalkanoates; Prohibitins | 2012 |